Company Analysis iBio, Inc.
1. Summary
Advantages
- The stock's return over the last year (403.44%) is higher than the sector average (-36.94%).
- Current debt level 5.98% is below 100% and has decreased over 5 years from 58.22%.
Disadvantages
- Price (1.82 $) is higher than fair price (1.65 $)
- Dividends (0%) are below the sector average (1.24%).
- The company's current efficiency (ROE=-116.8%) is lower than the sector average (ROE=-80.94%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| iBio, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -31.8% | 0% | -0.1% |
| 90 days | -20.4% | -43.3% | 8.8% |
| 1 year | 403.4% | -36.9% | 31.7% |
IBIO vs Sector: iBio, Inc. has outperformed the "Healthcare" sector by 440.38% over the past year.
IBIO vs Market: iBio, Inc. has outperformed the market by 371.73% over the past year.
Stable price: IBIO is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: IBIO with weekly volatility of 7.76% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1.82 $) is higher than the fair price (1.65 $).
Price is higher than fair: The current price (1.82 $) is 9.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (57.99).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.41).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.3756) is lower than that of the sector as a whole (9.41).
P/BV vs Market: The company's P/BV (0.3756) is lower than that of the market as a whole (22.54).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (35.59) is higher than that of the sector as a whole (4.07).
P/S vs Market: The company's P/S indicator (35.59) is higher than that of the market as a whole (15.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0.1159) is lower than that of the sector as a whole (17.44).
EV/Ebitda vs Market: The company's EV/Ebitda (0.1159) is lower than that of the market as a whole (22.02).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 8.31% over the last 5 years.
Earnings Slowdown: The last year's return (-15.03%) is below the 5-year average return (8.31%).
Profitability vs Sector: The return for the last year (-15.03%) is lower than the return for the sector (-14.25%).
5.4. ROE
ROE vs Sector: The company's ROE (-116.8%) is lower than that of the sector as a whole (-80.94%).
ROE vs Market: The company's ROE (-116.8%) is lower than that of the market as a whole (16.9%).
5.5. ROA
ROA vs Sector: The company's ROA (-86.68%) is lower than that of the sector as a whole (6.66%).
ROA vs Market: The company's ROA (-86.68%) is lower than that of the market as a whole (6.57%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.24%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
